A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05590377 · TERMINATED
Trial details
- NCT number
- NCT05590377
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2024-05-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.